HARLIKU
Live / Applied — Statement of use — processing complete, to examiner (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 20 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98760928
- Mark type
- Stylized text
- Filed
- 20 Sept 2024
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Mary Frances Love
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of alkaptonuria
Owner
- Cycle Pharmaceuticals Ltd, Cambridge, GB
- Cycle Pharmaceuticals Ltd, Cambridge, GB
Prosecution history
- 23 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Sept 2025 — USE AMENDMENT FILED
- 20 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2025 — ASSIGNED TO EXAMINER
- 20 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Sept 2024 — NEW APPLICATION ENTERED